As of 2025-09-18, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (38.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.03 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -422.4%.
The range of the Relative Valuation is (31.14) - (43.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (31.14) - (43.62) | (38.78) |
| Upside | -358.8% - -462.6% | -422.4% |
| Date | P/E |
| 2025-09-10 | -4.19 |
| 2025-09-09 | -4.04 |
| 2025-09-08 | -4.09 |
| 2025-09-05 | -4.35 |
| 2025-09-04 | -4.13 |
| 2025-09-03 | -4.16 |
| 2025-09-02 | -3.86 |
| 2025-08-29 | -3.78 |
| 2025-08-28 | -3.79 |
| 2025-08-27 | -3.77 |
| 2025-08-26 | -3.71 |
| 2025-08-25 | -3.63 |
| 2025-08-22 | -3.76 |
| 2025-08-21 | -3.74 |
| 2025-08-20 | -3.60 |
| 2025-08-19 | -3.59 |
| 2025-08-18 | -3.74 |
| 2025-08-15 | -3.71 |
| 2025-08-14 | -3.54 |
| 2025-08-13 | -3.59 |
| 2025-08-12 | -3.45 |
| 2025-08-11 | -3.27 |
| 2025-08-08 | -3.24 |
| 2025-08-07 | -3.31 |
| 2025-08-06 | -3.39 |
| 2025-08-05 | -3.41 |
| 2025-08-04 | -3.30 |
| 2025-08-01 | -3.27 |
| 2025-07-31 | -3.26 |
| 2025-07-30 | -3.37 |
| 2025-07-29 | -3.43 |
| 2025-07-28 | -3.52 |
| 2025-07-25 | -3.65 |
| 2025-07-24 | -3.53 |
| 2025-07-23 | -3.48 |
| 2025-07-22 | -3.27 |
| 2025-07-21 | -3.31 |
| 2025-07-18 | -3.27 |
| 2025-07-17 | -3.36 |
| 2025-07-16 | -3.31 |
| 2025-07-15 | -3.23 |
| 2025-07-14 | -3.45 |
| 2025-07-11 | -3.33 |
| 2025-07-10 | -3.41 |
| 2025-07-09 | -3.33 |
| 2025-07-08 | -3.04 |
| 2025-07-07 | -2.94 |
| 2025-07-03 | -3.03 |
| 2025-07-02 | -3.07 |
| 2025-07-01 | -2.99 |